Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-20-051046

Director bought 10,000 shares at $0.67 ($6,731)

From the SEC's structured data for this filing

Trades in this filing

Sukhtian Faisal Ghiath · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-17 Purchase : show line 1 in the form +10,000 $0.67 $6,731 10,000 D
Open-market purchases · 10,000 sh · avg $0.67 · $6,731
Loading xslF345X03/doc4.xml…